Twitter.com@CarolineFifeMD Last week we established that the risk of not participating in PQRS is not limited to the penalties of PQRS. There are penalties for your Value Modifier tied to PQRS. You have two options for participating in PQRS as a wound care and/or hyperbaric medicine practitioner.
One way you can participate in PQRS is to report the Diabetes Measure Group. The advantage of reporting the measure group is that you only have to report on 20 patients and only the “majority” of them have to be Medicare patients. That means that it is pretty easy to just pick 20 of your diabetic patients (at least 11 of which are Medicare beneficiaries) and input the data for the measures in a registry for reporting. The US Wound Registry is one of the most economical ways to do that.
Here is a link to the details of the Diabetes Measure Group, and the U.S. Wound Registry where you can report your data.
20 Patient Sample Method via registries: 20 unique patients (a majority of which must be Medicare Part B FFS patients) meeting patient sample criteria for the measures group during the reporting period (January 1 through December 31, 2015).
Measure #1 (NQF 0059): Diabetes: Hemoglobin A1c – Poor Control Patients whose most recent HbA1c level (performed during the measurement period) is > 9.0%
Measure #110 (NQF 0041): Preventive Care and Screening: Influenza Immunization – Percentage of patients aged 6 months and older seen for a visit between October 1 and March 31 who received an influenza immunization OR who reported previous receipt of an influenza immunization.
Measure #117 (NQF 0055): Diabetes: Eye Exam – Percentage of patients 18-75 years of age with a diagnosis of diabetes (type 1 and type 2) who had a retinal or dilated eye exam by an eye care professional in the measurement period or a negative retinal or dilated eye exam (negative for retinopathy) in the year prior to the measurement period.
Measure #119 (NQF 0062): Diabetes: Medical Attention for Nephropathy – The percentage of patients 18-75 years of age with diabetes who had a nephropathy screening test or evidence of nephropathy during the measurement period.
Measure #163 (NQF 0056): Diabetes: Foot Exam – Percentage of patients aged 18-75 years of age with diabetes who had a foot exam during the measurement period.
Measure #226 (NQF 0028): Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention – Percentage of patients aged 18 years and older who were screened for tobacco use one or more times within 24 months AND who received cessation counseling intervention if identified as a tobacco user.